RWRobert Wierzbowski

Robert Wierzbowski

*This is an algorithmically generated author record based on publicly available information.

Robert Wierzbowski has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2011
      • Vol. 69  (12) , 1266-71

    Resolution of exercise oscillatory ventilation with adaptive servoventilation in patients with chronic heart failure and Cheyne-Stokes respiration: preliminary study.

    by Anna Kazimierczak, Krystian Krzyżanowski, Robert Wierzbowski, Robert Ryczek, Paweł Smurzyński, Dariusz Michałkiewicz, Zbigniew Orski, Grzegorz Gielerak

    Exercise oscillatory ventilation (EOV) is a common pattern of breathing in heart failure (HF) patients, and indicates a poor prognosis. To investigate the effects of adaptive servoventilation (ASV) on ventilatory response during exercise. We studied 39 HF patients with left ventricular ejection fraction (LVEF) £ 45. Cardiorespiratory polygraphy, cardiopulmonary exercise testing (CPET), echocardiography, and measurement of N-terminal pro-brain natriuretic peptide (NT-proBNP) concentration were performed. Twenty patients with Cheyne-Stokes respiration and apnoea-hypopnoea index (AHI) ≥ 15/h were identified. Of these, 11 patients were successfully titrated on ASV and continued therapy. In the third month of ASV treatment, polygraphy, CPET, echocardiography, and measurement of NT-proBNP concentration were performed again. The EOV was detected at baseline in 12 (31%) HF patients, including eight (67%) who underwent ASV. The EOV was associated with significantly lower LVEF, peak oxygen uptake (VO(2)), and ventilatory anaerobic threshold (VAT), and a significantly higher left ventricular diastolic diameter (LVDD), slope of ventilatory equivalent for carbon dioxide (VE/VCO(2)), AHI, central AHI and NT-proBNP concentration. In seven patients with EOV, reversal of EOV in the third month of ASV therapy was observed; only in one patient did EOV persist (p = 0.0156). The EOV can be reversed with ASV therapy. The EOV in association with central sleep apnoea and Cheyne- -Stokes respiration (CSA/CSR) is prevalent in HF patients and correlates with severity of the disease.


    • 1 August 2009
      • Vol. 67  (8) , 927-9

    [Inappropriate therapy of an implantable cardioverter-defibrillator--is it always an undesired event? A case report].

    by Krystian Krzyzanowski, Dariusz Michałkiewicz, Robert Wierzbowski, Anna Gniłka, Robert Ryczek, Zbigniew Orski, Leszek Kubik

    Inappropriate implantable cardioverter defibrillator (ICD) therapy is the commonest adverse event in patients with ICD. We present a case of sinus rhythm restoration after an inappropriate shock in a man with permanent atrial fibrillation and dilated cardiomyopathy. During follow-up, clinical improvement has been observed.

    • 1 January 2007
      • Vol. 14  (6) , 561-7

    Long-term reproducibility of microvolt T-wave alternans in patients after cardioverter-defibrillator implantation.

    by Robert Wierzbowski, Dariusz Michałkiewicz, Karol Makowski, Paweł Smurzyński, Robert Ryczek, Andrzej Cwetsch, Marian Cholewa

    Microvolt T-wave alternans (MTWA) is a promising method for noninvasive assessment of arrhythmic risk. Recent studies have shown good immediate reproducibility of T-wave alternans. Little is known about it during the long term. The aim of the study was to prospectively evaluate the long-term reproducibility of MTWA in a group of patients after ICD implantation. The study group consisted of 22 patients: 21 male and 1 female, aged 63.0 +/- 7.6 years. Nineteen of them had a history of myocardial infarction and 3 had non-ischemic cardiomyopathy. Ejection fraction was 34.7 +/- 10.0. T-wave alternans was measured during treadmill tests and additionally in 6 patients during implantation cardioverter-defibrillator device pacing. We received 30 reports of MTWA available for analysis. The second test was performed after 11.8 +/- 3.3 months (range 7-16) using the same protocol. Of the 30 tests, 12 were positive, 2 negative and 9 indeterminate in both tests. The results were concordant in 23 tests (76.66%) (Kappa 0.602). Of the initial positive tests, only one became negative in the second test and 4 became indeterminate. Of the initial negative tests, none became positive and none became indeterminate. Of the initial indeterminate tests, one became positive and one negative. At the same time, there were no significant differences between QRS, QTc and ejection fraction between the first and second tests. Only the heart rate in the second test was greater than in the first. The results suggest that microvolt T-wave alternans measurement is stable over a long period. It is probably not worth examining the status of MTWA after several months, at least if patients are in the chronic stage of their disease. (Cardiol J 2007; 14: 561-567).


    • 1 October 2006
      • Vol. 21  (124) , 310-3

    [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].

    by Robert Wierzbowski, Dariusz Michałkiewicz, Marian Cholewa, Katarzyna Jacewicz, Anna Gniłka, Jerzy Adamus

    Microvolt T-wave alternans (MTWA) is promising method for noninvasive assessment of arrhythmic risk, but its role hasn't established yet. The aim of this study was to establish the MTWA potency to predict the ventricular arrhythmia triggering during implantable cordioverter-defibrillator (ICD) implantation. Material and metods. The study group consisted of 21 patients, aged 63.0+/-8.0 years; EF was 38.0+/-12.8%. Seventeen of them had a history of myocardial infarction and 4 had non-ischemic cardiomyopathy. The reason for ICD implantation were secondary prevention due to nonfatal cardiac arrest caused by VF/VT in nineteen patients and in two patients ICD was implanted because of unexplained syncope and low EF (< or =35%). All patients underwent VT/VF triggering during device implantation caused by electrophysiological study (EPS). If this proved ineffective aggressive protocol of 50 Hz BURST and T SHOCK was applied. After ICD implantation the following tests were performed: ECG with HR, QRS and QTc evaluation, 24-hour ECG Holter monitoring with HRV assessment and MTWA evaluation during treadmill exercise test. Results. In the group with VT/VF induced by less aggressive protocol (EPS), group I (n = 10) MTWA was present in nine patients, in one the result of MTWA was indeterminate. In the group with VT/VF induced by more aggressive protocol, group II (n = 11) MTWA was present in four patients, indeterminate in four and absent in three. There was a significant (p = 0.017) difference between group I and II in the frequency of positive result of MTWA. There were no differences between the two groups according to time domain parameters of HRV such as SDNN, RMSSD and PNN50 and QTc. There was a significant difference between the two groups in time duration of QRS complexes, 118.9+/-14.7 vs. 105.6+/-11.5 accordingly (p < 0.04). Conclusions. MTWA may help identify patients in whom VTNVF is more easily inducible by electrophysiologic study during ICD implantation. It is easier to induce ventricular arrhythmia when QRS complexes are wider, irrelevant to left ventricular dysfunction and autonomic function of the heart.